Cargando…

Will polygenic risk scores for cancer ever be clinically useful?

Detalles Bibliográficos
Autores principales:	Sud, Amit, Turnbull, Clare, Houlston, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139954/ https://www.ncbi.nlm.nih.gov/pubmed/34021222 http://dx.doi.org/10.1038/s41698-021-00176-1

Ejemplares similares

The clinical utility of polygenic risk scores for chronic lymphocytic leukemia
por: Sud, Amit, et al.
Publicado: (2021)

Realistic expectations are key to realising the benefits of polygenic scores
por: Sud, Amit, et al.
Publicado: (2023)

Polygenic risk scores to stratify cancer screening should predict mortality not incidence
por: Vickers, Andrew J., et al.
Publicado: (2022)

Prospects for using risk scores in polygenic medicine
por: Lewis, Cathryn M., et al.
Publicado: (2017)

The potential of polygenic scores to improve cost and efficiency of clinical trials
por: Fahed, Akl C., et al.
Publicado: (2022)

Polygenic risk score opportunities for early detection and prevention strategies in endometrial cancer
por: O’Mara, Tracy A., et al.
Publicado: (2020)

Polygenic risk scores for prediction of atrial fibrillation
por: Kavousi, Maryam, et al.
Publicado: (2022)

Understanding the ever-changing incidence of thyroid cancer
por: Kitahara, Cari M., et al.
Publicado: (2020)

Mentoring is more important than ever
por: Heemstra, Jennifer M., et al.
Publicado: (2022)

Progress in islet transplantation is more important than ever
por: Bornstein, Stefan R., et al.
Publicado: (2022)

Polygenic susceptibility to testicular cancer: implications for personalised health care
por: Litchfield, Kevin, et al.
Publicado: (2015)

Polygenic susceptibility to testicular cancer: implications for personalised health care
por: Litchfield, Kevin, et al.
Publicado: (2016)

Effect of COVID-19 on colorectal cancer care in England
por: Turnbull, Clare
Publicado: (2021)

Second cancer risk following Hodgkin lymphoma
por: Sud, Amit, et al.
Publicado: (2017)

The COVID-19 vaccines rush: participatory community engagement matters more than ever
por: Burgess, Rochelle Ann, et al.
Publicado: (2021)

Hereditary breast cancer: ever more pieces to the polygenic puzzle
por: Bogdanova, Natalia, et al.
Publicado: (2013)

The ever expanding scope of electrospray mass spectrometry—a 30 year journey
por: Mann, Matthias
Publicado: (2019)

Applying the science of learning to EdTech evidence evaluations using the EdTech Evidence Evaluation Routine (EVER)
por: Kucirkova, Natalia, et al.
Publicado: (2023)

Will it ever change? Lack of parental leave and its detrimental effects on maternal well-being
por: Jefferson, Erin E.Y.
Publicado: (2023)

Covid-19 and the need for perinatal mental health professionals: now more than ever before
por: Hynan, Michael T.
Publicado: (2020)

Potential use of clinical polygenic risk scores in psychiatry – ethical implications and communicating high polygenic risk
por: Palk, A. C., et al.
Publicado: (2019)

Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis
por: Horton, Rachel H., et al.
Publicado: (2022)

Polygenic risk scores in the clinic: Translating risk into action
por: Lewis, Anna C.F., et al.
Publicado: (2021)

Are polygenic risk scores ready for the cancer clinic?—a perspective
por: Klein, Robert J., et al.
Publicado: (2022)

Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History
por: Sud, Amit, et al.
Publicado: (2017)

On cross-ancestry cancer polygenic risk scores
por: Fritsche, Lars G., et al.
Publicado: (2021)

Polygenic Risk Scores for cancer mortality prediction
por: Sciurti, A, et al.
Publicado: (2023)

Polygenic risk score: use in migraine research
por: Chalmer, Mona Ameri, et al.
Publicado: (2018)

Polygenic risk scores in psychiatry: Will they be useful for clinicians?
por: Fullerton, Janice M., et al.
Publicado: (2019)

Polygenic risk scores and breast cancer risk prediction
por: Roberts, Eleanor, et al.
Publicado: (2023)

Prostate cancer risk prediction using a polygenic risk score
por: Sipeky, Csilla, et al.
Publicado: (2020)

Integrating genome-wide polygenic risk scores and non-genetic risk to predict colorectal cancer diagnosis using UK Biobank data: population based cohort study
por: Briggs, Sarah E W, et al.
Publicado: (2022)

Risk Assessment for Heroin Use and Craving Score Using Polygenic Risk Score
por: Huang, Chieh-Liang, et al.
Publicado: (2021)

Applicability of polygenic risk scores in endometriosis clinical presentation
por: Svensson, Agnes, et al.
Publicado: (2022)

Risk Stratification and Clinical Utility of Polygenic Risk Scores in Ophthalmology
por: Qassim, Ayub, et al.
Publicado: (2021)

Polygenic risk scores and their potential clinical use in psychiatry: are we there yet?
por: Fries, Gabriel R.
Publicado: (2020)

Polygenic transcriptome risk scores (PTRS) can improve portability of polygenic risk scores across ancestries
por: Liang, Yanyu, et al.
Publicado: (2022)

Lung cancer risk score for ever and never smokers in China
por: Ma, Zhimin, et al.
Publicado: (2023)

Genome-wide homozygosity signature and risk of Hodgkin lymphoma
por: Sud, Amit, et al.
Publicado: (2015)

Predicting Risk of Hypertension Among Childhood Cancer Survivors: A Polygenic Score to the Rescue?
por: Agrawal, Saaket, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gu5d0pnpvcitgq41t3q3it47uh